Scaling Mobile Technologies and Digital Biomarkers to Personalize Therapy Development

Jiao Li is a Digital Technology Lead of Digital Strategy Dept. at Chugai Pharmaceutical, a member of Roche Group. She joined Chugai as founding member of the Digital Biomarker Group, which focuses on leveraging digital health technologies to support drug development and maximize post-market drug value. Currently she is leading the first digital health project at Chugai in collaboration with external partners as Digital Technology Lead. She brings work experience in consulting and IT, and holds a Master’s in Biomedical and Health Informatics from the University of North Carolina at Chapel Hill.

Jaydev Thakkar, Chief Operating Officer of Biofourmis currently leads global operations across various business functions, including Customer Success, Sales and Marketing Operations, Clinical Research Operations and Supply Chain. Mr Thakkar has over 25 years of experience in leadership roles at organizations that include fortune 100 companies and rapidly growing start-ups. Prior to Biofourmis, Mr Thakkar was instrumental in founding a Digital Health and Innovation group at world’s leading biotech, Amgen, where he served for 14 years. During this time, Mr Thakkar led its “beyond the therapy” digital innovation strategy to maximize product value and clinical outcomes across the patient journey—from clinical development through product launch and post-marketing. At Amgen, Mr Thakkar also led information technology operations for the company’s large portfolio of global clinical trials—including some of the largest ever in the industry, with more than 27,000 participants across 50 countries and more than 1,000 sites. Before Amgen, Mr Thakkar was a telecommunications, technology and finance consultant who co-founded a technology startup and also managed his family’s manufacturing business in India.